These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38415729)

  • 41. [Dermatologic manifestations of the antiphospholipid syndrome].
    Francès C; Barete S; Soria A
    Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical manifestations of APS-nephropathy in primary antiphospholipid syndrome].
    Shilov EM; Kozlovskaia NL; Meteleva NA; Kozlovskaia LV; Varshavskiĭ VA; Miroshnichenko NG; Blokhina GV; Serova AG; Nesterova SG; Smolianitskiĭ AIa
    Ter Arkh; 2003; 75(6):22-7. PubMed ID: 12920954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The antiphospholipid syndrome, an update].
    Alonso Santor JE; Inglada Galiana L; Pérez Paredes G
    An Med Interna; 2007 May; 24(5):242-8. PubMed ID: 17907891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation.
    Sangle SR; D'Cruz DP; Abbs IC; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Mar; 44(3):372-7. PubMed ID: 15572388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review.
    Escoda T; George J; Jarrot PA; Jean R; Mazodier K; Sanderson F; Poullin P; Saby L; Jourde-Chiche N; Kaplanski G; Chiche L
    Lupus; 2022 May; 31(6):744-753. PubMed ID: 35341372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catastrophic antiphospholipid syndrome presenting as fever of unknown origin.
    Al-Beladi FI
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):110-3. PubMed ID: 22237230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal involvement in antiphospholipid syndrome.
    de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
    Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous microvascular occlusion syndrome as the first manifestation of catastrophic lupus-associated antiphospholipid antibody syndrome: a case report.
    Hosseini NS; Babaei S; Rahimi H; Gheissari A; Sedaghat B; Pourmahdi-Boroujeni M; Abtahi-Naeini B
    J Med Case Rep; 2023 Aug; 17(1):375. PubMed ID: 37605287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of antiphospholipid syndrome.
    Uthman I; Noureldine MHA; Ruiz-Irastorza G; Khamashta M
    Ann Rheum Dis; 2019 Feb; 78(2):155-161. PubMed ID: 30282668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinal arterial and venous obstruction as the first manifestation of an antiphospholipid antibody syndrome.
    Pérez-Crespo A; Gutiérrez-Ortiz C
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Jul; 96(7):380-383. PubMed ID: 34217476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.
    Gaspar P; Sciascia S; Tektonidou MG
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI24-SI36. PubMed ID: 38320589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute Myocardial Infarction Due to Antiphospholipid Syndrome - Case Report and Review of the Literature.
    Semczuk-Kaczmarek K; Platek AE; Ryś-Czaporowska A; Szymanski FM; Filipiak KJ
    Curr Probl Cardiol; 2021 Mar; 46(3):100552. PubMed ID: 32216971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome.
    Vaidya B; Nakarmi S; Joshi R; Baral R
    JNMA J Nepal Med Assoc; 2019; 57(216):133-145. PubMed ID: 31477950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
    Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
    Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of antiphospholipid syndrome.
    Rahman A
    Clin Rheumatol; 2020 Jul; 39(7):2111-2114. PubMed ID: 32458245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.